{"prompt": "['-', 'As non-measurable new lesions: all other new lesions are identified as non-target lesions and are followed in the', 'following evaluations.', 'An evaluation of these new lesions satisfies rules established by RECIST 1.1 (see following table)', 'Measurable NL', 'Non-measurable NL', 'Occurrence of NL', 'Overall response NL', 'CR', 'CR', 'No', '=', 'CR', 'CR', 'Non-CR/Non-PD', 'No', '=', 'PR', 'CR', 'Not evaluated', 'No', '=', 'PR', 'PR', 'Non-PD or not all evaluated', 'No', '=', 'PR', 'SD', 'Non-PD or not all evaluated', 'No', '=', 'SD', 'Not all evaluated', 'Non-PD', 'No', '=', 'Not evaluable (NE)', 'PD*', 'Indifferent', 'Yes or no', '=', 'PD', 'Indifferent', 'PD', 'Yes or no', '=', 'PD', 'Indifferent', 'Indifferent', 'Yes', '=', 'PD', '*For measurable new lesions, progression is observed if an increase of at least 5 mm.', '**For non-measurable new lesions, progression is observed if an increase is indisputable.', 'Overall response:', 'The overall response is the conjunction of target lesions, non-target lesions, new lesions; each type of lesion should be', 'considered first individually and then in a combined manner for overall response.', 'Following observation of an unconfirmed progression (iUPD), in the following evaluation (4 to 8 weeks later), the overall', 'response will be:', '-', 'Confirmed progression (iCPD), if observation of a further new progression of measurable target lesions and/or of', 'non-target lesions and/or of new lesions', '-', 'Re-initialisation of response in other cases (iCR, iPR or iSD)', 'In this case, a new cycle iUPD and then iCPD will be necessary in order to conclude in failure of therapy because of disease', 'progression. This rule applies for all categories of lesions followed (target lesions, non-target lesions and new lesions).', 'This concept makes it possible to take into account typical responses in immunotherapy, i.e. responses to postponement which', 'occurred after pseudo-progression.', 'PRODIGE 59 - DURIGAST -', 'Version 2.0 - 04.08.2020 ENG', 'Page 87 de 123']['Allocation of overall response according to iRECIST criteria:', 'If no non-target lesion is followed, the overall response is based on the result of response of target lesions, new lesions and overall response in previous evaluations.', 'Evaluation at time t', 'Overall response in previous evaluation (t-1)', 'Overall response at time t', 'Target lesion Response', 'Non-target lesion', 'Overall response of New lesions', 'response', 'iCR', 'iCR', 'Absence or CR', 'Indifferent', 'iCR', 'iCR', 'iCR', 'PR or NE', 'Indifferent', 'iPR', 'iCR', 'iCR', 'SD', 'Indifferent', 'iSD', 'iCR', 'Neither iCR - nor iUPD', 'Absence or CR', 'Indifferent', 'iPR', 'iCR', 'Neither iCR - nor iUPD', 'PR or NE', 'Indifferent', 'iPR', 'iCR', 'Neither iCR - nor iUPD', 'SD', 'Indifferent', 'iSD', 'iPR', 'Neither iCR - nor iUPD', 'Absence or CR or PR or NE', 'Indifferent', 'iPR', 'iPR', 'Neither iCR - nor iUPD', 'SD', 'Indifferent', 'iSD', 'iSD', 'Neither iCR - nor iUPD', 'Absence or non-PD', 'Indifferent', 'iSD', 'iUPD', 'Neither iCR - nor iUPD', 'Absence or non-PD', 'Neither iUPD/iCPD', 'iUPD', 'Neither iUPD/iCPD', 'iUPD', 'Absence or non-PD', 'Neither iUPD/iCPD', 'iUPD', 'iUPD', 'Neither iUPD/iCPD', 'Absence', 'iUPD - observed solely for target lesions', 'iUPD', 'Neither iUPD/iCPD', 'iUPD', 'Absence', 'iUPD observed solely for non-target lesions', 'iUPD', 'iUPD', 'iUPD', 'Absence', 'Neither iUPD/iCPD', 'iUPD', 'iUPD', 'iUPD', 'Absence', 'iUPD - observed for target lesions and non-target lesions', 'iUPD', 'Non-iCPD', 'Non-iCPD', '1st occurrence', 'Neither iUPD/iCPD', 'iUPD', 'indifferent', 'indifferent', '1st occurrence', 'iUPD - observed solely for target lesions and/or non-target lesions', 'iCPD', 'iUPD', 'indifferent', 'indifferent', 'iUPD - observed for non-target lesions and/or occurrence of new lesions', 'iCPD', 'indifferent', 'iUPD', 'indifferent', 'iUPD - observed for target lesions and/or occurrence of new lesions', 'iCPD', 'indifferent', 'indifferent', 'PD', 'Indifferent', 'iCPD', 'iCPD', 'indifferent', 'indifferent', 'Indifferent', 'iCPD', 'indifferent', 'iCPD', 'indifferent', 'Indifferent', 'iCPD', 'PRODIGE 59 - DURIGAST -', 'Version 2.0 - 04.08.2020 ENG', 'Page 88 de 123']\n\n###\n\n", "completion": "END"}